4//SEC Filing
Gayko Urte 4
Accession 0001599298-22-000034
CIK 0001599298other
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 4:36 PM ET
Size
5.5 KB
Accession
0001599298-22-000034
Insider Transaction Report
Form 4
Gayko Urte
Director
Transactions
- Award
Stock Option (right to buy)
2022-04-25+400,000→ 400,000 totalExercise: $1.93Exp: 2032-04-25→ Common Stock (400,000 underlying)
Footnotes (2)
- [F1]The option was granted on April 25, 2022. The shares underlying the option are scheduled to vest in four equal annual installments over four years.
- [F2]Not applicable.
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001559217
Filing Metadata
- Form type
- 4
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 4:36 PM ET
- Size
- 5.5 KB